21 CFR Explained for Pharma | Part 11, 210 & 211 | USFDA GMP & Data Integrity

What is 21 CFR in the Pharmaceutical Industry? In this complete and practical guide, we explain 21 CFR Title 21, Part 210, Part 211 and Part 11 in simple language with real pharmaceutical QC/QA examples. You’ll learn: ✅ What is 21 CFR? ✅ 21 CFR Part 210 – GMP framework ✅ 21 CFR Part 211 – Finished Pharmaceuticals ✅ 21 CFR Part 11 – Electronic Records & Electronic Signatures ✅ Data Integrity & ALCOA+ ✅ QC Laboratory Controls ✅ SOP, Documentation & Records ✅ OOS & Deviation Investigation ✅ CAPA & Change Control ✅ FDA Inspection & “Show Me the Evidence” ✅ Practical QC Analyst workflow from Sample → SOP → HPLC → Chromatogram → Review → Documentation → QA Approval This video is useful for Pharma QC, QA, Production, Regulatory Affairs, Validation, GMP professionals, B.Pharm/M.Pharm students and anyone preparing for USFDA inspections or pharmaceutical interviews. 21 CFR Part 210 and Part 211 are key CGMP regulations for drug manufacturing and finished pharmaceuticals, while Part 11 addresses electronic records and electronic signatures within its applicable scope. Remember: Quality is not just a result — it is the evidence that the result can be trusted. #21CFR #Pharma #USFDA #GMP #PharmaceuticalIndustry #DataIntegrity #Part11 #Part211 #PharmaQA #PharmaQC